Aristada (Aripiprazole Lauroxil)

Aristada (aripiprazole lauroxil) is a long-acting intramuscular injection for the treatment of schizophrenia in adults. Depending on the dose, it is given once a month, every 6 weeks or every 2 months, which can help patients who struggle to take daily tablets stay on treatment.

Aripiprazole lauroxil is a prodrug that is slowly converted to aripiprazole in the body. Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at 5-HT2A receptors, helping to control symptoms such as hallucinations and delusions. Treatment is started together with oral aripiprazole or the Aristada Initio regimen.

• Boxed warning: elderly patients with dementia-related psychosis treated with antipsychotics have an increased risk of death. Aristada is not approved for this use.
• Tolerability to aripiprazole should be established before the first injection.
• Possible risks include neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes (blood sugar, lipids, weight), low blood pressure on standing, seizures and impulse-control problems.
• The most common side effect is akathisia (restlessness); injection-site reactions may also occur.

Is Aristada sold in India?

Aristada is an imported medicine and is not readily available through regular pharmacies in India. It can still be accessed legally on a named-patient basis, subject to Indian import regulations.

Which papers do I need to send?

Because Aristada is brought in for a specific patient, the following are required before we can place the order:

• A valid prescription from a registered psychiatrist
• Psychiatric assessment confirming the diagnosis of schizophrenia
• Patient ID proof issued by the Government of India

How does confirmation work?

Once the prescription has been verified, we confirm the order and share the expected timeline.

Need Aristada? Our team works with licensed distributors abroad to bring it in for individual patients and institutions, following Indian import rules.

Price and delivery details: +91-9310090915 | info@indianpharmanetwork.in

Global Approval Status:

• United States: FDA-approved in October 2015 for schizophrenia in adults.

What is Aristada (Aripiprazole Lauroxil) prescribed for?

Aristada is a long-acting injectable atypical antipsychotic indicated for schizophrenia in adults.

Who markets Aristada?

Aristada comes from Alkermes.

How often is Aristada given?

Depending on the dose prescribed, it is injected once monthly, every 6 weeks or every 2 months by a healthcare professional.

How does Aristada help?

Aripiprazole lauroxil is a prodrug that is slowly converted to aripiprazole in the body.

What is the FDA status of Aristada?

Yes. Aristada is FDA-approved for the treatment of schizophrenia in adults.